208 related articles for article (PubMed ID: 16305369)
1. An MDR-EGFP gene fusion allows for direct cellular localization, function and stability assessment of P-glycoprotein.
Pétriz J; Gottesman MM; Aran JM
Curr Drug Deliv; 2004 Jan; 1(1):43-56. PubMed ID: 16305369
[TBL] [Abstract][Full Text] [Related]
2. Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin Cif.
Ye S; MacEachran DP; Hamilton JW; O'Toole GA; Stanton BA
Am J Physiol Cell Physiol; 2008 Sep; 295(3):C807-18. PubMed ID: 18650266
[TBL] [Abstract][Full Text] [Related]
3. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
4. Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation.
Fu D; Roufogalis BD
Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1543-52. PubMed ID: 17122416
[TBL] [Abstract][Full Text] [Related]
5. Similarities and differences in the localization, trafficking, and function of P-glycoprotein in MDR1-EGFP-transduced rat versus human brain capillary endothelial cell lines.
Gericke B; Borsdorf S; Wienböker I; Noack A; Noack S; Löscher W
Fluids Barriers CNS; 2021 Aug; 18(1):36. PubMed ID: 34344390
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced trafficking of p-glycoprotein in human brain capillary endothelial cells as demonstrated by exposure to mitomycin C.
Noack A; Noack S; Hoffmann A; Maalouf K; Buettner M; Couraud PO; Romero IA; Weksler B; Alms D; Römermann K; Naim HY; Löscher W
PLoS One; 2014; 9(2):e88154. PubMed ID: 24505408
[TBL] [Abstract][Full Text] [Related]
7. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.
Hitzl M; Drescher S; van der Kuip H; Schäffeler E; Fischer J; Schwab M; Eichelbaum M; Fromm MF
Pharmacogenetics; 2001 Jun; 11(4):293-8. PubMed ID: 11434506
[TBL] [Abstract][Full Text] [Related]
8. In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity.
Chen Y; Simon SM
J Cell Biol; 2000 Mar; 148(5):863-70. PubMed ID: 10704438
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
[TBL] [Abstract][Full Text] [Related]
10. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN
Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476
[TBL] [Abstract][Full Text] [Related]
11. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp).
Jansson PJ; Yamagishi T; Arvind A; Seebacher N; Gutierrez E; Stacy A; Maleki S; Sharp D; Sahni S; Richardson DR
J Biol Chem; 2015 Apr; 290(15):9588-603. PubMed ID: 25720491
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells.
Maraldi NM; Zini N; Santi S; Scotlandi K; Serra M; Baldini N
Biol Cell; 1999 Jan; 91(1):17-28. PubMed ID: 10321019
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein.
Benderra Z; Trussardi A; Morjani H; Villa AM; Doglia SM; Manfait M
Eur J Cancer; 2000 Feb; 36(3):428-34. PubMed ID: 10708946
[TBL] [Abstract][Full Text] [Related]
14. Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells.
Dupuis ML; Ascione A; Palmisano L; Vella S; Cianfriglia M
BMC Pharmacol Toxicol; 2013 Sep; 14():47. PubMed ID: 24053678
[TBL] [Abstract][Full Text] [Related]
15. Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance associated protein and P-glycoprotein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Adv Exp Med Biol; 1999; 457():151-60. PubMed ID: 10500790
[TBL] [Abstract][Full Text] [Related]
16. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein.
Ruth A; Stein WD; Rose E; Roninson IB
Biochemistry; 2001 Apr; 40(14):4332-9. PubMed ID: 11284689
[TBL] [Abstract][Full Text] [Related]
17. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
18. Modulation of multidrug resistance with antisense oligodeoxynucleotide to mdr1 mRNA.
Sola JE; Colombani PM
Ann Surg Oncol; 1996 Jan; 3(1):80-5. PubMed ID: 8770307
[TBL] [Abstract][Full Text] [Related]
19. Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line.
Gong Y; Wang Y; Chen F; Han J; Miao J; Shao N; Fang Z; Ou Yang R
Leuk Res; 2000 Sep; 24(9):769-74. PubMed ID: 10978781
[TBL] [Abstract][Full Text] [Related]
20. Intracellular Doppler Spectroscopy detects altered drug response in SKOV3 tumor spheroids with silenced or inhibited P-glycoprotein.
Narayanan G; Merrill D; An R; Nolte DD; Turek JJ
Biochem Biophys Res Commun; 2019 Jul; 514(4):1154-1159. PubMed ID: 31103263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
